Sources | Names Used |
---|---|
CTRPv2 | BRD-K16130065 |
PharmacoGx | BRD-K16130065 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SRD5A2 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0005 |
mRNA | AP1B1 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |
mRNA | RAB3B | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0006 |
mRNA | CCDC91 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0006 |
mRNA | GALNT9 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0006 |
mRNA | PYY | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0006 |
mRNA | AKR1C3 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0006 |
mRNA | RINL | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0006 |
mRNA | AIRE | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0006 |
mRNA | AACS | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |